Michael Bliziotes

2.0k total citations
36 papers, 1.5k citations indexed

About

Michael Bliziotes is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Bliziotes has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Orthopedics and Sports Medicine, 11 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Bliziotes's work include Bone health and osteoporosis research (13 papers), Vitamin D Research Studies (9 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Michael Bliziotes is often cited by papers focused on Bone health and osteoporosis research (13 papers), Vitamin D Research Studies (9 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Michael Bliziotes collaborates with scholars based in United States, France and Italy. Michael Bliziotes's co-authors include Stuart J. Warden, Kristine M. Wiren, Amy J. Eshleman, Charles H. Turner, Elizabeth M Haney, Alexander G. Robling, Stephen J. Marx, Mark S. Nanes, M. Gunness and Robyn K. Fuchs and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Biochemical Journal.

In The Last Decade

Michael Bliziotes

36 papers receiving 1.5k citations

Peers

Michael Bliziotes
JP Bonjour Switzerland
Don McMahon United States
J. Collette Belgium
Margaret R. Warner United States
Maurice F. Attie United States
Michael Bliziotes
Citations per year, relative to Michael Bliziotes Michael Bliziotes (= 1×) peers Julia Lindgren

Countries citing papers authored by Michael Bliziotes

Since Specialization
Citations

This map shows the geographic impact of Michael Bliziotes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bliziotes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bliziotes more than expected).

Fields of papers citing papers by Michael Bliziotes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bliziotes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bliziotes. The network helps show where Michael Bliziotes may publish in the future.

Co-authorship network of co-authors of Michael Bliziotes

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Bliziotes. A scholar is included among the top collaborators of Michael Bliziotes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Bliziotes. Michael Bliziotes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calarge, Chadi A., et al.. (2013). Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents. Therapeutic Advances in Psychopharmacology. 3(5). 278–293. 35 indexed citations
2.
Calarge, Chadi A., Vicki L. Ellingrod, Bridget Zimmerman, Michael Bliziotes, & Janet Schlechte. (2011). Variants of the Serotonin Transporter Gene, Selective Serotonin Reuptake Inhibitors, and Bone Mineral Density in Risperidone-Treated Boys. The Journal of Clinical Psychiatry. 72(12). 1685–1690. 14 indexed citations
3.
Warden, Stuart J., et al.. (2010). Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels. Bone. 46(4). 985–992. 47 indexed citations
4.
Bliziotes, Michael. (2010). Update in Serotonin and Bone. The Journal of Clinical Endocrinology & Metabolism. 95(9). 4124–4132. 74 indexed citations
5.
Warden, Stuart J., Alexander G. Robling, Elizabeth M Haney, Charles H. Turner, & Michael Bliziotes. (2009). The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5). Bone. 46(1). 4–12. 79 indexed citations
6.
Haney, Elizabeth M, Stuart J. Warden, & Michael Bliziotes. (2009). Effects of selective serotonin reuptake inhibitors on bone health in adults: Time for recommendations about screening, prevention and management?. Bone. 46(1). 13–17. 86 indexed citations
7.
Haney, Elizabeth M & Michael Bliziotes. (2008). Male osteoporosis: new insights in an understudied disease. Current Opinion in Rheumatology. 20(4). 423–428. 24 indexed citations
8.
Warden, Stuart J., et al.. (2008). Serotonin (5-hydroxytryptamine) transporter inhibition causes bone loss in adult mice independently of estrogen deficiency. Menopause The Journal of The North American Menopause Society. 15(6). 1176–1183. 64 indexed citations
9.
Sauer, David, et al.. (2007). Metastatic Papillary Thyroid Carcinoma Presenting as a Long-Standing Calcified Neck Mass. Thyroid. 17(8). 799–800. 1 indexed citations
10.
Haney, Elizabeth M & Michael Bliziotes. (2007). Selective serotonin reuptake inhibitors and bone health. 2(2). 213–222. 5 indexed citations
11.
Bliziotes, Michael, Amy J. Eshleman, Brigitte Burt‐Pichat, et al.. (2006). Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone. 39(6). 1313–1321. 99 indexed citations
12.
Warden, Stuart J., Michael Bliziotes, Kristine M. Wiren, Amy J. Eshleman, & Charles H. Turner. (2005). Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine). Molecular and Cellular Endocrinology. 242(1-2). 1–9. 58 indexed citations
13.
Haney, Elizabeth M, Diane Stadler, & Michael Bliziotes. (2004). Vitamin D Insufficiency in Internal Medicine Residents. Calcified Tissue International. 76(1). 11–16. 38 indexed citations
14.
Orwoll, Eric & Michael Bliziotes. (2003). Osteoporosis : pathophysiology and clinical management. Humana Press eBooks. 4 indexed citations
15.
Bliziotes, Michael, et al.. (2001). Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone. 29(5). 477–486. 177 indexed citations
16.
Bliziotes, Michael, et al.. (2000). Reduced G-protein-coupled-receptor kinase 2 activity results in impairment of osteoblast function. Bone. 27(3). 367–373. 16 indexed citations
17.
Bliziotes, Michael, S. W. McLoughlin, M. Gunness, et al.. (2000). Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter gene. Bone. 26(1). 15–19. 55 indexed citations
18.
Bliziotes, Michael, Alfred L. Yergey, Mark S. Nanes, et al.. (1988). Absent Intestinal Response to Calciferols in Hereditary Resistance to 1,25-Dihydroxyvitamin D: Documentation and Effective Therapy With High Dose Intravenous Calcium Infusions*. The Journal of Clinical Endocrinology & Metabolism. 66(2). 294–300. 36 indexed citations
19.
Marx, Stephen J., Michael Bliziotes, & Mark S. Nanes. (1986). ANALYSIS OF THE RELATION BETWEEN ALOPECIA AND RESISTANCE TO 1,25‐DIHYDROXYVITAMIN D. Clinical Endocrinology. 25(4). 373–381. 65 indexed citations
20.
Bliziotes, Michael, Stephen B. Lewis, & J. Hamilton Licht. (1982). Dose-Related Influence of Indomethacin on Parathyroid Hormone-Stimulated Adenosine 3′,5′-Monophosphate Release from the Perfused Rat Hindlimb*. Endocrinology. 111(5). 1657–1662. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026